Literature DB >> 10517504

Axonal pathology in multiple sclerosis. A historical note.

B Kornek1, H Lassmann.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10517504     DOI： 10.1111/j.1750-3639.1999.tb00547.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN： 1015-6305            Impact factor:   6.508


× No keyword cloud information.
  41 in total

Review 1.  Recent neuropathological findings in MS--implications for diagnosis and therapy.

Authors:  Hans Lassmann
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.

Authors:  LiPing Liu; Lindsey Darnall; Taofang Hu; Karen Choi; Thomas E Lane; Richard M Ransohoff
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

Review 3.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

4.  Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).

Authors:  D Offen; J F Kaye; O Bernard; D Merims; C I Coire; H Panet; E Melamed; A Ben-Nun
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

Review 5.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

6.  Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.

Authors:  Itzy E Morales Pantoja; Che-Lin Hu; Nora I Perrone-Bizzozero; Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2016-09-19       Impact factor: 5.372

7.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Che-Lin Hu; Mara Nydes; Kara L Shanley; Itzy E Morales Pantoja; Tamara A Howard; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2018-12-03       Impact factor: 5.372

Review 9.  Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders.

Authors:  Ruth Arnon; Rina Aharoni
Journal:  Mol Neurobiol       Date:  2007-10-11       Impact factor: 5.590

10.  Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.

Authors:  Ike de la Pena; Mibel Pabon; Sandra Acosta; Paul R Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  Cell Med       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.